Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2024

Despite developments in circulating biomarker and imaging technology in the assessment of cardiovascular disease, the surveillance and diagnosis of heart transplant rejection has continued to rely on histopathologic interpretation of the endomyocardial biopsy.

Heart Transplant 64

Heart Transplant Transplant Biomarkers Technology 64

DAIC

FEBRUARY 2, 2024

Course Chairs are: Ana Barac, MD, PhD, FACC , Inova Health System ; and Bonnie Ky, MD, MSCE, FACC , University of Pennsylvania, Perelman School of Medicine. Course Vice Chair is Richard Cheng, MD, MSc, FACC , University of Washington.

Cardio Oncology 95

Cardio Oncology Cancer Pharmacology RN 95

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Kidney Disease Diabetes 59

Cardiometabolic Health Congress

MARCH 8, 2024

Her research focuses on women’s cardiovascular health and cardio-obstetrics, cardiovascular risk prediction using coronary artery calcium scores and biomarkers, lipids, and cardiometabolic diseases.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Dr. Malcolm Kendrick

OCTOBER 30, 2024

The hypothesis that a raised cholesterol level causes heart disease [atherosclerotic cardiovascular disease (ASCVD)] is possibly the single most powerful idea in medicine. Which remains the single most influential study on cardiovascular disease, ever. At least some of it. It was simply a matter of time.

Cholesterol 145

Cholesterol Article Research Diet 145